BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, June 13, 2025
Breaking News: Trump administration impacts continue to roil the life sciences sector
Breaking News: After iffy adcom, FDA clears Urogen’s Zusduri mitomycin
Breaking News: Trump administration impacts continue to roil the life sciences sector
Breaking News: Trump administration impacts continue to roil the life sciences sector
Home
»
Topics
» BioWorld Science, Neurology/psychiatric
BioWorld Science, Neurology/psychiatric
RSS
NMDA antagonists claimed by E. Merck
Aug. 9, 1996
Dainippon's new compound superior to metoclopramide for digestive function improvement
Aug. 9, 1996
Teva's Copaxone progresses toward FDA approval
Aug. 9, 1996
5-HT1A agonist with alpha1-adrenoceptor-blocking properties from Byk Gulden
Aug. 9, 1996
Multiuse melatonergic 3-alkoxybenzylpiperidine derivatives from Bristol-Myers Squibb
Aug. 9, 1996
ADIR describes compunds with high affinity for 5-HT2C and/or 5-HT3C receptors
Aug. 9, 1996
Lidocaine nasal drops shown effective for fast migraine pain relief
Aug. 9, 1996
5-HT1 agonists described by Merck & Co.
Aug. 9, 1996
Actiq to undergo phase III clinical trials
Aug. 9, 1996
Menarini and Lilly sign comarketing agreement
Aug. 9, 1996
Previous
1
2
…
2715
2716
2717
2718
2719
2720
2721
2722
2723
…
2748
2749
Next
RSS